Top News
Nov 25, 2024
FDA Approves BridgeBio Pharma’s Drug for Rare Heart Disease

On Friday, the FDA approved BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization. The FDA approval is based on ATTRibute-CM Phase 3 study…

Top News
Nov 22, 2024
What’s Going On With Tapestry Stock Today?

Tapestry, Inc. (NYSE:TPR) has entered into Accelerated Share Repurchase agreements with Bank of America N.A. and Morgan Stanley & Co. LLC to repurchase $2.0 billion shares of common stock. While recently announcing its termination of Capri Holdings merger agreement, the company revealed…

Top News
Nov 13, 2024
Netflix Stock Hit A New All-Time High: What’s Going On?

Netflix Inc (NASDAQ:NFLX) shares are trading higher by roughly 9% to $832 in November, marking a new all-time high. The stock has gained amid overall market strength after Donald Trump's re-election, with investors anticipating that his pro-business, tax-cutting agenda could…

Top News
Nov 11, 2024
Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim analyst John Difucci downgraded the rating for Smartsheet Inc.…